Clever Fruit to Pitch Innovative Cholesterol Management Product at Natural Product Canada’s First Virtual Pitch Event

By December 3, 2019February 28th, 2020No Comments

For immediate release:

Clever Fruit Products (“Clever Fruit”) is pleased to announce it has been selected to participate in Natural Products Canada (NPC) first virtual pitch event. The event will introduce innovative new Canadian products and companies to investors, corporations, and other strategic partners.

The event takes place on December 3, 2019 and Clever Fruit is one of only four promising Canadian companies in the natural health product industry who will be participating. “It is our pleasure to be invited to this event,” says Liam Tayler, President of Clever Fruit. “After we attended NPC’s Annual NCN Investor Meeting in the fall, our fermented nutraceutical ingredient generated a lot of positive interest from investors. We are very excited and honored to be participating in this virtual pitch event.”

About Natural Products Canada:

Natural Products Canada (NPC) originated with the idea that Canada could be a global leader in the multi-billion-dollar natural products sector. NPC is Canada’s Centre of Excellence for Commercialization and Research of natural products, funded by the National Centres of Excellence along with numerous private and public partners who share the belief in this untapped opportunity. NPC is fostering and aligning the commercialization ecosystem to bring validated natural products to market – faster, cheaper, and more efficiently.

About Clever Fruit Products:

Clever Fruit Products (“Clever Fruit”) manufactures a fermented nutraceutical ingredient to manage cholesterol naturally. Clever Fruit’s technology is a unique approach to fermentation that draws out the full nutrient profile of the underlying fruit while creating new compounds. Its initial product is based on the wild blueberry and early trials suggest a potential to reduce cholesterol by 40% and reduce LDL oxidation, lowering the possibility of plaque formation in the arteries.

For more information, please contact: